Abstract:Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterized by demyelination. Current treatment options for MS focus on immunosuppression, but their efficacy can be limited. Recent studies suggest a potential role for nerve injury-induced protein 1 (NINJ1) in MS pathogenesis. NINJ1, a protein involved in cell death and inflammation, may contribute to the infiltration and activation of inflammatory cells in the CNS, potentially through enhanced blood–brain barrier crossing; enhancing plasma membrane rupture during cell death, leading to the release of inflammatory mediators and further tissue damage. This review explores the emerging evidence for NINJ1′s involvement in MS. It discusses how NINJ1 might mediate the migration of immune cells across the blood–brain barrier, exacerbate neuroinflammation, and participate in plasma membrane rupture-related damage. Finally, the review examines potential therapeutic strategies targeting NINJ1 for improved MS management. Abbreviations: MS, Multiple sclerosis; CNS, Central nervous system; BBB, Blood-brain barrier; GSDMD, Gasdermin-D; EAE, Experimental autoimmune encephalitis; HMGB-1, High mobility group box-1 protein; LDH, Lactate dehydrogenase; PMR, Plasma membrane rupture; DMF, Dimethyl fumarate; DUSP1, Dual-specificity phosphatase 1; PAMPs, Pathogen-associated molecular patterns; DAMPs, Danger-associated molecular patterns; PRRs, Pattern recognition receptors; GM-CSF, Granulocyte-macrophage colony stimulating factor; IFN-γ, Interferon gamma; TNF, Tumor necrosis factor; APCs, Antigen-presenting cells; ECs, Endothelial cells; TGF-β, Transforming growth factor-β; PBMCs, Peripheral blood mononuclear cells; FACS, Fluorescence-activated cell sorting; MCP-1, Monocyte chemoattractant protein-1; NLRP3, Pyrin domain-containing 3; TCR, T cell receptor; ROS, Reactive oxygen species; AP-1, Activator protein-1; ANG1, Angiopoietin 1; BMDMs, Bone marrow-derived macrophages; Arp2/3, actin‐related protein 2/3; EMT, epithelial–mesenchymal transition; FAK, focal adhesion kinase; LIMK1, LIM domain kinase 1; PAK1, p21‐activated kinases 1; Rac1, Ras‐related C3 botulinum toxin substrate 1; β‐cat, β‐caten; MyD88, myeloid differentiation primary response gene 88; TIRAP, Toll/interleukin-1 receptor domain-containing adapter protein; TLR4, Toll-like receptor 4; IRAKs, interleukin-1 receptor-associated kinases; TRAF6, TNF receptor associated factor 6; TAB2/3, TAK1 binding protein 2/3; TAK1, transforming growth factor-β-activated kinase 1; JNK, c-Jun N-terminal kinase; ERK1/2, Extracellular Signal Regulated Kinase 1/2; IKK, inhibitor of kappa B kinase; IκB, inhibitor of NF-κB; NF-κB, nuclear factor kappa-B; AP-1, activator protein-1; ASC, Apoptosis-associated Speck-like protein containing a CARD; NEK7, NIMA-related kinase 7; NLRP3, Pyrin domain-containing 3; CREB, cAMP response element-binding protein.

Regulation of Neuroinflammation: What Role for the Tumor Necrosis Factor-Like Weak Inducer of Apoptosis/Fn14 Pathway?

IκBα Deficiency in Brain Leads to Elevated Basal Neuroinflammation and Attenuated Response Following Traumatic Brain Injury: Implications for Functional Recovery

TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier

Inflammation Mediates Varying Effects in Neurogenesis: Relevance to the Pathogenesis of Brain Injury and Neurodegenerative Disorders

The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system

Neuroinflammation: Extinguishing a blaze of T cells

The potential for treg-enhancing therapies in nervous system pathologies

NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review

Non-coding RNAs and neuroinflammation: implications for neurological disorders

NINJ1: A new player in multiple sclerosis pathogenesis and potential therapeutic target

Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases

Targeting cytokine networks in neuroinflammatory diseases

Guard of Delinquency? A Role of Microglia in Inflammatory Neurodegenerative Diseases of the CNS

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

The Role of Regulatory T Cells in Neurodegenerative Diseases

Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment

The role of inflammation in CNS injury and disease

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update

The impact of neuroinflammation on neuronal integrity